Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. - Wikidata - awgldk - TriplyDB

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

http://www.wikidata.org/entity/Q33866015

about

Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma Role of EZH2 polymorphisms in esophageal squamous cell carcinoma risk in Han Chinese population.Important aspects of nutrition in children with cancer.Correlation between insulin‑like growth factor binding protein 3 and metastasis‑associated gene 1 protein in esophageal squamous cell carcinoma.Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.Prognostic factors in clinical T1N0M0 thoracic esophageal squamous cell carcinoma invading the muscularis mucosa or submucosa.Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.Safety and efficacy of radiation and chemoradiation in patients over 70 years old with inoperable esophageal squamous cell carcinoma.Clinical prognostic factors for locally advanced esophageal squamous carcinoma treated after definitive chemoradiotherapy.Full costs of dispensing and administering fluorouracil chemotherapy for outpatients: A microcosting study.Four Distinct Health Profiles in Older Patients With Cancer: Latent Class Analysis of the Prospective ELCAPA Cohort.Predictors of 1-Year Mortality in a Prospective Cohort of Elderly Patients With Cancer.Outcome for esophageal cancer following treatment with chemotherapy and radiotherapy but not esophagectomy: Nonsurgical treatment of esophageal cancer.Definitive chemoradiotherapy in patients with esophageal adenocarcinoma: an alternative to surgery?The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma.Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy.Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.Nonoperable patients with superficial esophageal cancer treated by photodynamic therapy after chemoradiotherapy have more severe complications than patients treated in primary intent.Shifting practice in definitive chemoradiation for localized esophageal cancer.A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma.Endoscopic traversability in patients with locally advanced esophageal squamous cell carcinoma: Is it a significant prognostic factor?Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients.Comparison of the prognosis of neoadjuvant chemoradiotherapy treatment with surgery alone in esophageal carcinoma: a meta-analysis.Excessive Pretreatment Weight Loss Is a Risk Factor for the Survival Outcome of Esophageal Carcinoma Patients Undergoing Radical Surgery and Postoperative Adjuvant Chemotherapy.Impact of Sarcopenia in Patients with Unresectable Locally Advanced Esophageal Cancer Receiving Chemoradiotherapy.Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients

P2860

Q28073933-AA71170C-657B-447B-9C45-EE7417417D8B Q33764809-A5993545-C658-4C73-91A1-E94A713BA4AE Q34072487-768E6B74-F56F-499E-AD75-7D0D46DF121B Q34729831-41106E9E-A496-44D3-9EBF-642F95F4B4FA Q36817315-B5DF21EA-C641-4372-9C67-1B7358F3BD2E Q36977519-DC3D09D9-B439-4BCE-BD30-C6A1CA994A87 Q37024365-64AD5C40-A181-4079-B611-9E4146860759 Q37160122-187C273A-96ED-49EA-8DB1-0B085FBE7B06 Q37388685-C6847344-F130-4A07-8ABB-17743693F806 Q37484572-99EAD4BA-6BB3-4146-8947-ED66A62A18B2 Q37626116-1FA0E89C-860F-4FE2-B1B1-183E9F6F33E6 Q39896359-921C43BB-14E9-4E75-A8A2-E404D4AC0777 Q41124813-532FE78B-5A33-490E-82DC-FC5EF200965F Q42731854-C6632656-B0DA-43A5-B924-BBCC832ABDC9 Q44247708-69A54B8B-6F6E-4CBF-9B4E-A0F14D450634 Q44594186-18281B6B-F088-4682-B2DF-1058D6C68F94 Q45818724-E32FECB9-BE09-464B-911B-1C4D1E4526C0 Q45954716-2795F58A-DFFB-497E-B138-BB6C6FDBCA2E Q46323928-354C508D-E2DA-47D4-B468-56ACC5AC55D3 Q47168592-E4B44773-A9DE-43E5-991B-86FB6E5F809D Q48334688-2159560F-1E00-4B84-AD58-07CC0D5F8CD6 Q49164810-FAB27445-7F96-405B-A515-49DAF0A4DEF2 Q54267061-18CAF75F-5472-4592-BB40-1C0ECC05826D Q55382030-F2A88B73-2429-4AD9-BC48-89057D95C234 Q55416218-6AFC63C1-D180-4B97-86A3-18440DD16DE1 Q55428382-FAC6B7A4-889C-4973-95E7-5262F0050D60 Q56782923-83D460F7-A467-44A7-BA68-F6E83D24EA21 Q58781949-400D43B0-FC11-4C51-A7FA-1243D979F543 Q59126164-524C4EBF-F0F9-4299-9974-0C23C6BE2904

P2860

Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma.

http://www.wikidata.org/entity/Q33866015

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Predictive factors of survival ...... ous cell esophageal carcinoma.

@ast

Predictive factors of survival ...... ous cell esophageal carcinoma.

@en

type

label

Predictive factors of survival ...... ous cell esophageal carcinoma.

@ast

Predictive factors of survival ...... ous cell esophageal carcinoma.

@en

prefLabel

Predictive factors of survival ...... ous cell esophageal carcinoma.

@ast

Predictive factors of survival ...... ous cell esophageal carcinoma.

@en

P1433

Q33866015-7ECE3C99-9371-40E6-BBE6-507995570A10

P1476

Q33866015-4E650968-4150-4E95-85AB-BA6956419AF1

P2093

Q33866015-158B0397-4ABA-4827-978D-E4F3127BDF81

Q33866015-2F94D779-437E-4DF6-B89B-62A5EA5FFE51

Q33866015-3721E9D0-C12F-41A0-8E07-994586B0C646

Q33866015-4DBFD541-6D37-42E7-AEFB-8EC9C9B5C68E

Q33866015-7BE299ED-89C2-40BB-AED7-1D4599671BFA

Q33866015-8503EF4F-8F8E-4F14-8199-A9B8C38B6C99

Q33866015-9740B02E-8B9C-4A91-9D8A-819C1F4D6781

Q33866015-9859F190-49B6-44A8-B127-98ED33A435FB

Q33866015-FCC4886E-14E5-47FF-AD4C-3AA90C1C7FEA

P2860

Q33866015-0F079A41-8151-4C6D-8936-05F3A361D7A8

Q33866015-2003B275-DD76-4B45-9DE2-A25BB4B7BAE1

Q33866015-2339819F-C56C-4C67-BF19-4CD239F0D626

Q33866015-25DE753F-624A-4397-A597-CC0F2C6A569C

Q33866015-26363B48-DFC1-4B60-8F30-6BFE9006D5A1

Q33866015-27C28E4E-97E2-4543-BC0A-77E5ACCE33E2

Q33866015-3B75BE53-170A-4379-BC79-96849B616875

Q33866015-4C731479-9336-41BA-A909-F31442674BC7

Q33866015-6A07F31B-A2EB-4913-8970-723AAE8DD5DA

Q33866015-6B82E313-5959-41FC-B3A0-4C292A7FCC35

P304

Q33866015-6D6C99FB-F317-4FD3-A8B1-9DE0BCD06D1C

P31

Q33866015-99901260-34BA-4CF4-A3A4-EE4CE34E298B

P356

Q33866015-99AEFE42-1E91-4CC9-A490-A45AB036007F

P407

Q33866015-6F8AAF1C-570F-4187-8E6E-DF83233AEE2F

P433

Q33866015-8805368C-CA86-4BD3-ACE4-7C592B014DF7

P478

Q33866015-373FAFE9-1356-4230-AC08-4F010848FC15

P577

Q33866015-1F616FB8-1B3B-4495-9A6E-F9A6D66F08CB

P5875

Q33866015-672525DA-5C27-4322-B651-BC6A9831F8A6

P698

Q33866015-9AA04012-1D69-4861-871D-D1D10217C717

P921

Q33866015-62382EDF-0B24-45CB-90EF-C4E4BE7EF982

P932

Q33866015-059CC9F1-4C95-4BA7-A2EB-0D734AB82F2E

P356

WJG.V12.I26.4185

P1433

World Journal of Gastroenterology

P1476

Predictive factors of survival ...... ous cell esophageal carcinoma.

@en

P2093

Bernard Paillot

http://www.w3.org/2001/XMLSchema#string

Emmanuel Ben Soussan

http://www.w3.org/2001/XMLSchema#string

Frederic Di Fiore

http://www.w3.org/2001/XMLSchema#string

Isabelle David

http://www.w3.org/2001/XMLSchema#string

Jacques-Henri Jacob

http://www.w3.org/2001/XMLSchema#string

Marie-Pierre Galais

http://www.w3.org/2001/XMLSchema#string

Olivier Rigal

http://www.w3.org/2001/XMLSchema#string

Pierre Michel

http://www.w3.org/2001/XMLSchema#string

Stephane Lecleire

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative TN staging of esophageal cancer: comparison of miniprobe ultrasonography, spiral CT and MRI.

Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials.

Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data.

Clinical staging of esophageal carcinoma. CT, EUS, and PET.

Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy.

Gastrointestinal cancers in Europe.

Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival.

Definitive chemoradiotherapy for patients with malignant stricture due to T3 or T4 squamous cell carcinoma of the oesophagus.

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy.

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer.

P304

4185-4190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V12.I26.4185

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

298738126

http://www.w3.org/2001/XMLSchema#string

P698

16830371

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4087370

http://www.w3.org/2001/XMLSchema#string